Nexell Therapeutics, Inc.

Irvine, CA 92618

SBIR Award Summary

Total Number of Awards 3
Total Value of Awards $173K
First Award Date 08/01/99
Most Recent Award Date 08/01/01

Key Personnel

Last Name Name Awards Contact
Ross Amy A Ross 2
Bender James G Bender 1

3 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/01 - 08/31/02

DESCRIPTION (provided by applicant): Pre-clinical feasibility studies are presented to define a clinical system that selectively removes alloreactive T lymphocytes from allografts. The goal of these studies is the development a simple and automated process to generate therapeutic T cell products to support non-mye...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/00 - 07/31/01

The presence of low numbers of tumor cells (micrometastases) in hematopoietic tissues in patients with a variety of solid-tumor malignancies is of extreme clinical relevance. In breast prostate, and lung cancer patients, the presence of micrometastases is significantly associated with poor pr...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/99 - 07/31/00

The presence of low numbers of tumor cells (micrometastases) in hematopoietic tissues in patients with a variety of solid-tumor malignancies is of extreme clinical relevance. In breast prostate, and lung cancer patients, the presence of micrometastases is significantly associated with poor pr...